'At this time, there is no rapid, point-of-care test available in the US that clinicians can use to help distinguish a bacterial respiratory infection from a viral infection.'
That is the key takeaway.
This will be so huge if Lumos can get the FDA approval. Fingers crossed.
- Forums
- ASX - By Stock
- LDX
- Ann: Lumos Files Appeal To The FDA For FebriDx
Ann: Lumos Files Appeal To The FDA For FebriDx, page-2
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.92M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 280000 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 92437 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 480000 | 0.036 |
3 | 383000 | 0.035 |
3 | 791176 | 0.034 |
1 | 400000 | 0.033 |
3 | 512000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 92437 | 1 |
0.032 | 485 | 1 |
0.033 | 50000 | 1 |
0.034 | 334518 | 2 |
0.035 | 40000 | 1 |
Last trade - 09.48am 04/07/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online